Cargando…
Inhibition of Membrane-Bound BAFF by the Anti-BAFF Antibody Belimumab
B cell activating factor of the TNF family (BAFF, also known as BLyS), a cytokine that regulates homeostasis of peripheral B cells, is elevated in the circulation of patients with autoimmune diseases such as systemic lupus erythematosus (SLE). BAFF is synthetized as a membrane-bound protein that can...
Autores principales: | Kowalczyk-Quintas, Christine, Chevalley, Dehlia, Willen, Laure, Jandus, Camilla, Vigolo, Michele, Schneider, Pascal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256835/ https://www.ncbi.nlm.nih.gov/pubmed/30524439 http://dx.doi.org/10.3389/fimmu.2018.02698 |
Ejemplares similares
-
A loop region of BAFF controls B cell survival and regulates recognition by different inhibitors
por: Vigolo, Michele, et al.
Publicado: (2018) -
BAFF and BAFF-Receptor in B Cell Selection and Survival
por: Smulski, Cristian R., et al.
Publicado: (2018) -
No Evidence That Soluble TACI Induces Signalling via Membrane-Expressed BAFF and APRIL in Myeloid Cells
por: Nys, Josquin, et al.
Publicado: (2013) -
Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen
por: Hébert, Vivien, et al.
Publicado: (2021) -
B cell alterations during BAFF inhibition with belimumab in SLE
por: Ramsköld, Daniel, et al.
Publicado: (2018)